SCHEMBL1088686

SCHEMBL1088686

Cc1ccc2c(O)cc(-c3cccc(C)n3)nc2c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.48
CCR8 P51685 1/20 0.48
TGFBR1 P36897 2/20 0.41
CYP1A2 P05177 3/20 0.40
GRM5 P41594 1/20 0.39
METAP2 P50579 1/20 0.37
NQO2 P16083 1/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GAA P10253 1/20 0.35
PDE10A Q9Y233 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C8 P10632 1/20 0.34
CYP2A6 P11509 1/20 0.34
GRM2 Q14416 1/20 0.34
ALOX12 P18054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6809754 0.83 KDM4E (0.46) CCR1CCR8TGFBR1GRM5NQO2
SCHEMBL11941822 0.81 CDC7 (0.37) CYP1A2NQO2HSD17B10KDM4EALDH1A1
SCHEMBL10155099 0.78 KDM4E (0.56) CYP1A2HSD17B10KDM4EALDH1A1MEN1
SCHEMBL6593684 0.77 CYP1A2 (0.50) CYP1A2NQO2KDM4EALDH1A1GRM2
SCHEMBL11941734 0.77 CYP1A2 (0.38) CCR1CCR8CYP1A2GRM5NQO2
SCHEMBL4173614 0.73 CYP1A2 (0.50) CYP1A2METAP2KDM4EALDH1A1KMT2A
SCHEMBL15978468 0.73 TRPA1 (0.41) CYP1A2NQO2HSD17B10KDM4EALDH1A1
SCHEMBL15824289 0.72 CYP1A2 (0.63) CCR1CCR8TGFBR1CYP1A2METAP2
SCHEMBL12424718 0.72 CCR1 (0.47) CCR1CCR8TGFBR1METAP2CYP3A4
SCHEMBL996497 0.71 CCR1 (0.42) CCR1CCR8TGFBR1CYP1A2GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153800-B2 Macrocyclic inhibitors of hepatitis C virus TIBOTEC PHARMACEUTICALS LTD. (IE) 2012-04-10 US disclosed